Clinical Trials Browser

Phase 2 × Hypopharyngeal Neoplasms × nimotuzumab × Clear all

NCT01516996 2012-03-20

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

Phase 2 Unknown

Hypopharyngeal Neoplasms, Oropharyngeal Neoplasms